Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Octreotide 30mg powder and solvent for suspension for injection vials |
| BNF code | 0803043N0AAAFAF |
| Virtual Therapeutic Moiety | Octreotide |
| Date identifier became valid | 29 Oct 2018 |
| Previous product identifier | 327351009 |
| Abbreviated name | Octreotide 30mg inj vials |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 9 Jun 2004 |
| Previous name | Octreotide 30mg injection vials and diluent |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Octreotide acetate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 109053000 |
| Strength value numerator | 30.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | suspensioninjection.intramuscular-deep |
| Dose Form | |
| Formulation | Powder and solvent for suspension for injection |
| Drug Route | |
| Route | Intramuscular |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) | |
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Octreotide 30mg powder and solvent for suspension for injection vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.